Oscar Health (OSCR) EBIAT (2020 - 2025)
Oscar Health (OSCR) has disclosed EBIAT for 6 consecutive years, with -$352.4 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, EBIAT fell 129.32% year-over-year to -$352.4 million, compared with a TTM value of -$443.1 million through Dec 2025, down 1837.05%, and an annual FY2025 reading of -$442.9 million, down 1425.03% over the prior year.
- EBIAT was -$352.4 million for Q4 2025 at Oscar Health, down from -$137.4 million in the prior quarter.
- Across five years, EBIAT topped out at $275.3 million in Q1 2025 and bottomed at -$352.4 million in Q4 2025.
- Average EBIAT over 5 years is -$93.6 million, with a median of -$100.5 million recorded in 2021.
- The sharpest move saw EBIAT skyrocketed 547.87% in 2024, then tumbled 505.76% in 2025.
- Year by year, EBIAT stood at -$198.9 million in 2021, then dropped by 15.28% to -$229.3 million in 2022, then surged by 34.47% to -$150.3 million in 2023, then dropped by 2.27% to -$153.7 million in 2024, then crashed by 129.32% to -$352.4 million in 2025.
- Business Quant data shows EBIAT for OSCR at -$352.4 million in Q4 2025, -$137.4 million in Q3 2025, and -$228.5 million in Q2 2025.